LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
House
Bills
HB4434
US
US Federal House Bill HB4434
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal House Bill HB4434
Introduced
7/16/25
Refer
7/16/25
Caption
Cosmetic Supply Chain Transparency Act of 2025
Latest US HB4434 Activity
View All Events: US 2025-2026 Regular Session HB4434
Companion Bills
No companion bills found.
Previously Filed As
US HB1657
Humane Cosmetics Act of 2025
US SB3751
Prescription Drug Supply Chain Pricing Transparency Act
US HB1328
Supply Chain Security and Growth Act of 2025
US SB229
DTC Act of 2025 Drug-price Transparency for Consumers Act of 2025
US HB4435
Cosmetic Hazardous Ingredient Right to Know Act of 2025
US H686
Safe Cosmetics Act
US HB8339
Drug Origin Transparency Act of 2026
US HB7777
Protecting America’s Medical Supply Chains Act of 2026
US HB1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
US HB3789
DTC Act of 2025 Drug-price Transparency for Consumers Act of 2025
Similar Bills
No similar bills found.